Logo image of ACHV

ACHIEVE LIFE SCIENCES INC (ACHV) Stock Fundamental Analysis

NASDAQ:ACHV - US0044685008 - Common Stock

2.98 USD
-0.14 (-4.49%)
Last: 8/27/2025, 4:59:58 PM
2.98 USD
0 (0%)
After Hours: 8/27/2025, 4:59:58 PM
Fundamental Rating

2

Overall ACHV gets a fundamental rating of 2 out of 10. We evaluated ACHV against 547 industry peers in the Biotechnology industry. ACHV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ACHV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ACHV has reported negative net income.
In the past year ACHV has reported a negative cash flow from operations.
ACHV had negative earnings in each of the past 5 years.
ACHV had a negative operating cash flow in each of the past 5 years.
ACHV Yearly Net Income VS EBIT VS OCF VS FCFACHV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

ACHV has a Return On Assets of -85.55%. This is in the lower half of the industry: ACHV underperforms 70.57% of its industry peers.
ACHV has a Return On Equity (-121.00%) which is in line with its industry peers.
Industry RankSector Rank
ROA -85.55%
ROE -121%
ROIC N/A
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACHV Yearly ROA, ROE, ROICACHV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K 2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACHV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACHV Yearly Profit, Operating, Gross MarginsACHV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

More info and screens

4

2. Health

2.1 Basic Checks

ACHV has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACHV has more shares outstanding
The debt/assets ratio for ACHV has been reduced compared to a year ago.
ACHV Yearly Shares OutstandingACHV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACHV Yearly Total Debt VS Total AssetsACHV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ACHV has an Altman-Z score of -1.77. This is a bad value and indicates that ACHV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ACHV (-1.77) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.21 indicates that ACHV is not too dependend on debt financing.
The Debt to Equity ratio of ACHV (0.21) is worse than 68.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z -1.77
ROIC/WACCN/A
WACCN/A
ACHV Yearly LT Debt VS Equity VS FCFACHV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 6.64 indicates that ACHV has no problem at all paying its short term obligations.
ACHV has a Current ratio of 6.64. This is in the better half of the industry: ACHV outperforms 65.63% of its industry peers.
A Quick Ratio of 6.64 indicates that ACHV has no problem at all paying its short term obligations.
ACHV's Quick ratio of 6.64 is fine compared to the rest of the industry. ACHV outperforms 66.36% of its industry peers.
Industry RankSector Rank
Current Ratio 6.64
Quick Ratio 6.64
ACHV Yearly Current Assets VS Current LiabilitesACHV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ACHV have decreased strongly by -31.53% in the last year.
EPS 1Y (TTM)-31.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-48%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 36.57% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1.03%
EPS Next 2Y7.66%
EPS Next 3Y25.78%
EPS Next 5Y36.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACHV Yearly Revenue VS EstimatesACHV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2021 2022 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
ACHV Yearly EPS VS EstimatesACHV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1K -2K -3K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACHV. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACHV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACHV Price Earnings VS Forward Price EarningsACHV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACHV Per share dataACHV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

ACHV's earnings are expected to grow with 25.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.66%
EPS Next 3Y25.78%

More info and screens

0

5. Dividend

5.1 Amount

ACHV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACHIEVE LIFE SCIENCES INC

NASDAQ:ACHV (8/27/2025, 4:59:58 PM)

After market: 2.98 0 (0%)

2.98

-0.14 (-4.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/amc
Inst Owners32.16%
Inst Owner Change79.87%
Ins Owners3.48%
Ins Owner Change0.68%
Market Cap152.28M
Analysts83.33
Price Target16.32 (447.65%)
Short Float %5.83%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.25%
Min EPS beat(2)0.16%
Max EPS beat(2)0.34%
EPS beat(4)2
Avg EPS beat(4)-11.2%
Min EPS beat(4)-35%
Max EPS beat(4)0.34%
EPS beat(8)4
Avg EPS beat(8)-3.03%
EPS beat(12)6
Avg EPS beat(12)-0.93%
EPS beat(16)8
Avg EPS beat(16)-0.32%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)14.29%
EPS NQ rev (1m)-3.05%
EPS NQ rev (3m)9.24%
EPS NY rev (1m)-0.36%
EPS NY rev (3m)2.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.65
P/tB 3.83
EV/EBITDA N/A
EPS(TTM)-1.46
EYN/A
EPS(NY)-1.03
Fwd EYN/A
FCF(TTM)-0.78
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS0
BVpS0.82
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -85.55%
ROE -121%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.64
Quick Ratio 6.64
Altman-Z -1.77
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-48%
EPS Next Y-1.03%
EPS Next 2Y7.66%
EPS Next 3Y25.78%
EPS Next 5Y36.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-97.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.11%
OCF growth 3YN/A
OCF growth 5YN/A